Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001510964-21-000027
Filing Date
2021-05-13
Accepted
2021-05-13 16:12:25
Documents
58
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cvsi-20210331.htm   iXBRL 10-Q 774933
2 EX-31.1 cvsi-20210331xex311.htm EX-31.1 9345
3 EX-31.2 cvsi-20210331xex312.htm EX-31.2 9321
4 EX-32.1 cvsi-20210331xex321.htm EX-32.1 4282
5 EX-32.2 cvsi-20210331xex322.htm EX-32.2 4251
  Complete submission text file 0001510964-21-000027.txt   4007090

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cvsi-20210331.xsd EX-101.SCH 26756
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cvsi-20210331_cal.xml EX-101.CAL 54903
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cvsi-20210331_def.xml EX-101.DEF 147210
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cvsi-20210331_lab.xml EX-101.LAB 399096
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cvsi-20210331_pre.xml EX-101.PRE 254963
11 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20210331_htm.xml XML 552511
Mailing Address 10070 BARNES CANYON ROAD SAN DIEGO CA 92121
Business Address 10070 BARNES CANYON ROAD SAN DIEGO CA 92121 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

EIN.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54677 | Film No.: 21919762
SIC: 2834 Pharmaceutical Preparations